Navigation Links
Drinking wine beneficial in dementia

According to a major medical study by researchers it is observed that drinking wine may have some health benefits. The latest from researchers in Denmark, observe that people who drink wine// now and again may have a lesser risk of developing dementia and Alzheimer's disease. People who drank wine weekly or monthly had the most benefit.

The researchers are realistic about their research. They say people should not suddenly start consuming larger amounts of wine for health reasons. Instead, they predict the healthy substances in wine may one day be identified and made into medications to treat the disease. They speculate it is the flavenoids in the wine that offer the protective effect.

Doctors studied 1,567 people and determined their drinking patterns from the 1975s. Then they looked for signs of dementia or Alzheimer's in the same group in the 1992s. They were able to document 75 people who developed dementia. Researchers then went back and compared alcohol intake of those individuals to those without dementia.

Authors of the study write, "Monthly and weekly intake of wine was significantly associated with a lower risk of dementia." However, drinking beer monthly was responsible for an increase in the risk for dementia.


'"/>




Page: 1

Related medicine news :

1. Drinking arsenic water leads to cancer
2. Alcoholism Drug Fails To Prevent Drinking Relapses
3. Heavy Drinking Raises Risk of Liver Cancer
4. Drinking wine as part of a healthy living
5. Drinking adequate amounts of water
6. Drinking milk: Good or bad?
7. Is Drinking Extra Fluids Safe When You’re Sick
8. Could Midlife Alcohol Drinking Lead To Dementia ?
9. Understanding The Link Between Metabolic Syndrome And Drinking Patterns
10. Heavy Drinking Can Increase Stroke Risk
11. Heredity Can Decide Your Drinking Habits
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2017)... DC (PRWEB) , ... March 30, 2017 , ... ... and organizations submitted a letter to President Trump expressing their support for an ... medical doctors, two Ph.D. scientists and one medical journalist, will hold a press ...
(Date:3/29/2017)... ... March 29, 2017 , ... In the United States alone, up ... year develop other types of metastatic brain tumors(3). Though most meningiomas are benign, metastatic ... focus on finding more effective treatment options, the San Diego Gamma Knife Center ...
(Date:3/29/2017)... ... 2017 , ... Grass pollen is the main cause of hay fever in the United States, ... grass pollen runs from May to July each year; with the worst time for sufferers ... allergen barrier balms ( http://www.haymax.us ) provide an effective defense against grass pollen; they are ...
(Date:3/29/2017)... FL (PRWEB) , ... March 30, 2017 , ... Sublime ... the "Spice of Life" or "Wonder Spice", it has been used for thousands of ... in the East," says Heshelow, author of " Turmeric: How to Use it For ...
(Date:3/29/2017)... ... March 29, 2017 , ... AngioGenesis Labs ... store in Mississippi. AngioGenesis Labs, makers of HeartBoost, BrainBest and BeautyBest, achieved these ... Ingredients in HeartBoost, an over the counter heart healthy drink, can reduce Arterial ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... -- Wound care devices and products are used to ... industry mainly consists of establishments engaged in manufacturing wound ... caused by mechanical, chemical, thermal, and radiogenic trauma; and ... skin related diseases, immunological diseases, and other chronic diseases. ... largest region in the wound care devices market in ...
(Date:3/29/2017)... , March 29, 2017 Global intravenous (IV) iron ... billion by 2021, growing at a CAGR of 5%. ... by a doctor to treat anemia or other iron deficiencies. ... in the body. However, in some cases, oral administrations are ... and intravenous (IV) iron therapy comes into the picture. ...
(Date:3/29/2017)... N.J. , March 29, 2017  Novartis ... Administration (FDA) has accepted the company,s Biologics License ... CTL019 (tisagenlecleucel-T), an investigational chimeric antigen receptor T ... pediatric and young adult patients with B-cell acute ... submission by Novartis for a CAR-T. The priority ...
Breaking Medicine Technology: